Delivery Order SPE2DB22D2009-SPE2DB23FM0WC
- Not listed
- This federal contract award, valued at $1,763.91, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract covers the delivery of 4,563,661 units of the HAVRIX 720 vaccine syringe (0.5 mL) to support military healthcare programs. The contract is a Delivery Order awarded under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026....
- This federal contract award, valued at $2,927.82, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of HAVRIX 1,440 UNIT/ML SYRINGEML medical supplies, with an ultimate completion date of November 20, 2023. This is a Firm Fixed Price Delivery Order contract, with no set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of HAVRIX 720 UNIT/0.5 ML SYRINGE 0.5ML. The contract has a firm fixed price of $1,003.86 and an ultimate completion date of June 2, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is a for-profit organization registered in the System for Award Management (SAM.gov). The contract was awarded...
- This federal contract award, with a value of $8,657.50, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of HAVRIX 720 UNIT/0.5 ML SYRINGE 0.5ML, a pharmaceutical product. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen Drug Corp holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 and...
- This federal contract award, valued at $2,712.48, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for HAVRIX 720 UNIT/0.5 ML SYRINGE 0.5ML, with a firm fixed price and an ultimate completion date of July 18, 2025. The award is not associated with a set-aside designation and is part of Amerisourcebergen Drug Corp's larger Indefinite Delivery Contract (IDC) with...
- This federal contract award, valued at $1,833.70, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of HAVRIX 1,440 UNIT/ML SYRINGEML, a pharmaceutical product. The award is a Delivery Order contract with a Firm Fixed Price pricing type and an ultimate completion date of August 14, 2023. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award, valued at $19,624.40, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of HAVRIX 1,440 UNIT/ML SYRINGE medical supplies. The contract has a firm fixed price and is a delivery order with an ultimate completion date of August 10, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,887.09, is for the delivery of HAVRIX 720/0.5ML 10S, a vaccine product. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract valued at $5,775.30 to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of HAVRIX 720 Unit/0.5 ML Syringe 0.5ML, a pharmaceutical product, with a completion date of January 6, 2023. This contract is not designated as a set-aside and is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to $999,999,999.00 and...
- This federal contract award is for the delivery of HAVRIX 1,440 UNIT/ML SYRINGEML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical. This IDC serves as the...
- SPE2DB22D2009Indefinite Delivery Contract
- SPE2DB22D2009-SPE2DB23FM0WCDelivery Order
This federal contract award, valued at $28,875.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of 4560970200 HAVRIX 720 UNIT/0.5 ML SYRINGE 0.5ML, a pharmaceutical product. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for Cencora, Inc. to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $28.9k | 5/17/23 |